Company Filing History:
Years Active: 2012
Title: The Innovations of John Elliott Humphries in Controlled Release Drug Products
Introduction: John Elliott Humphries is a notable inventor based in Chapel Hill, NC, whose contributions to the field of pharmaceuticals have had a significant impact on treating viral infections. His work primarily revolves around innovative drug delivery systems, which have the potential to improve patient outcomes.
Latest Patents: Humphries holds a patent for "Controlled Release Interferon Drug Products and Treatment of HCV Infections Using Same." This invention focuses on controlled release formulations that incorporate microparticles made from biodegradable polymers and one or more interferon compounds. The formulations aim to provide effective treatment options for patients suffering from Hepatitis C virus (HCV) infections.
Career Highlights: John Elliott Humphries has dedicated his career to advancements in biopharmaceuticals. He is currently associated with Biolex Therapeutics, Inc., where he applies his expertise to develop innovative therapies based on his research and patents.
Collaborations: Throughout his professional journey, Humphries has collaborated with various knowledgeable colleagues, including David Gelvin Spencer, Jr. and Leonardus Gerardus Jozef De Leede. These partnerships have fostered an environment of innovation and research that has enhanced the development of therapeutic solutions.
Conclusion: John Elliott Humphries exemplifies the spirit of innovation in the pharmaceutical industry. His patented work on controlled release drug products showcases his commitment to addressing significant healthcare challenges. Through his career and collaborations, he continues to contribute to advancements in the treatment of viral infections and further the field of drug development.